The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Patel, Shilpeshkumar Kanubhai
    Director born in December 1978
    Individual (6 offsprings)
    Officer
    2023-03-31 ~ now
    OF - Director → CIF 0
    Mr Shilpeshkumar Kanubhai Patel
    Born in December 1978
    Individual (6 offsprings)
    Person with significant control
    2023-03-31 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
parent relation
Company in focus

ASHA PHARMA LTD

Standard Industrial Classification
86900 - Other Human Health Activities
Brief company account
Fixed Assets - Investments
351,750 GBP2024-03-31
Fixed Assets
351,750 GBP2024-03-31
Debtors
6,435 GBP2024-03-31
Cash at bank and in hand
17,462 GBP2024-03-31
Current Assets
23,897 GBP2024-03-31
Net Current Assets/Liabilities
-15,975 GBP2024-03-31
Total Assets Less Current Liabilities
335,775 GBP2024-03-31
Net Assets/Liabilities
97,918 GBP2024-03-31
Equity
Called up share capital
1 GBP2024-03-31
Retained earnings (accumulated losses)
97,917 GBP2024-03-31
Equity
97,918 GBP2024-03-31
Average Number of Employees
02023-03-31 ~ 2024-03-31
Amounts invested in assets
Additions to investments, Non-current
351,750 GBP2024-03-31
Other Investments Other Than Loans
Non-current
351,750 GBP2024-03-31
Amounts invested in assets
Non-current
351,750 GBP2024-03-31
Trade Debtors/Trade Receivables
Amounts falling due within one year
6,435 GBP2024-03-31
Debtors
Amounts falling due within one year
6,435 GBP2024-03-31
Corporation Tax Payable
Amounts falling due within one year
22,633 GBP2024-03-31

Related profiles found in government register
  • ASHA PHARMA LTD
    Info
    Registered number 14771294
    177 Archer Road, Stevenage SG1 5HD
    Private Limited Company incorporated on 2023-03-31 (2 years 3 months). The company status is Active.
    The last date of confirmation statement was made at 2025-03-30
    CIF 0
  • ASHA PHARMA LTD
    S
    Registered number 14771294
    177, Archer Road, Stevenage, England, SG1 5HD
    Private Limited Company in The Registrar Of Companies For England And Wales, United Kingdom
    CIF 1
  • ASHA PHARMA LTD
    S
    Registered number 14771294
    231, Kenton Road, Harrow, Middlesex, England, HA3 0HD
    Company in Register Of Companies, England
    CIF 2
child relation
Offspring entities and appointments
Active 1
  • 231 Kenton Road, Harrow, Middlesex, England
    Active Corporate (4 parents, 1 offspring)
    Person with significant control
    2024-04-21 ~ now
    CIF 2 - Ownership of shares – More than 25% but not more than 50%OE
    CIF 2 - Ownership of voting rights - More than 25% but not more than 50%OE
    CIF 2 - Right to appoint or remove directorsOE
Ceased 1
  • 231 Kenton Road, Harrow, England
    Active Corporate (4 parents)
    Equity (Company account)
    947,211 GBP2024-03-31
    Person with significant control
    2023-06-30 ~ 2023-07-03
    CIF 1 - Ownership of shares – More than 25% but not more than 50% OE
    CIF 1 - Ownership of voting rights - More than 25% but not more than 50% OE
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.